| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS44039842 | HTLV-1 | ENSG00000164749.13 | protein_coding | HNF4G | No | No | 3174 | Q14541 |
| TVIS44039903 | HTLV-1 | ENSG00000164749.13 | protein_coding | HNF4G | No | No | 3174 | Q14541 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | HNF4G |
|---|---|
| DrugBank ID | DB03796 |
| Drug Name | Palmitic Acid |
| Target ID | BE0003179 |
| UniProt ID | Q14541 |
| Regulation Type | |
| PubMed IDs | |
| Citations | |
| Groups | Approved |
| Direct Classification | Long-chain fatty acids |
| SMILES | CCCCCCCCCCCCCCCC(O)=O |
| Pathways | Cerivastatin Action Pathway; Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCAD); Ethylmalonic Encephalopathy; Familial Hypercholanemia (FHCA); Desmosterolosis; Short-Chain Acyl-CoA Dehydrogenase Deficiency (SCAD Deficiency); Congenital Bile Acid Synthesis Defect Type III; Glycerolipid Metabolism; Ibandronate Action Pathway; Cerebrotendinous Xanthomatosis (CTX); Chondrodysplasia Punctata II, X-Linked Dominant (CDPX2); Smith-Lemli-Opitz Syndrome (SLOS); Carnitine Palmitoyl Transferase Deficiency II; Hyper-IgD Syndrome; Zellweger Syndrome; Long-Chain-3-Hydroxyacyl-CoA Dehydrogenase Deficiency (LCHAD); Steroid Biosynthesis; Hypercholesterolemia; Risedronate Action Pathway; Mevalonic Aciduria; Glutaric Aciduria Type I; Alendronate Action Pathway; CHILD Syndrome; D-Glyceric Acidura; Lovastatin Action Pathway; Wolman Disease; Bile Acid Biosynthesis; Long Chain Acyl-CoA Dehydrogenase Deficiency (LCAD); Glycerol Kinase Deficiency; Atorvastatin Action Pathway |
| PharmGKB | |
| ChEMBL | CHEMBL82293 |
